Carla Ferrándiz Pulido

Institutions of which they are part

Main researcher
Biomedical Research in Melanoma

Vall Hebron Institut de Recerca

Carla Ferrándiz Pulido

Institutions of which they are part

Main researcher
Biomedical Research in Melanoma

Vall Hebron Institut de Recerca

Projects

SCOPE - SCC metastasis study: phase 2

IP: Carla Ferrándiz Pulido
Collaborators: -
Funding agency: Fundación Academia Española Dermatología (FAEDV)
Funding: 5000
Reference: FAEDV/PROYECTO/2025/FERRANDIZ
Duration: 01/07/2025 - 31/12/2026

Related news

Equip de Vall d'Hebron que ha liderat l'estudi

We identify a therapeutic target to improve melanoma response to immunotherapy

The findings pave the way for the development of new therapeutic strategies combining immunotherapy with p38α protein inhibitors.

Laboratori de Recerca Biomèdica en Ginecologia del VHIR

VHIR cancer research advances from understanding tumours to personalised medicine

The ten groups within the Cancer Area combine basic, translational and clinical research to identify new targets, biomarkers and therapeutic strategies

We discover how exposure to UV radiation in newborns can lead to a type of melanoma

The study reveals that if the exposure of newborns to solar radiation of sufficient intensity to provoke a skin reaction is simultaneous with the activation of the BRAFv600E gene, it can trigger an uncontrolled proliferation of cancer cells.